Article
Colistin and polymyxin B: A re-emergence
1 Jan 2009
Abstract excerpt
One of the greatest achievements of modern medicine is the development of antibiotics against life-threatening infections, but the emergence of multidrug-resistant (MDR) gram negative bacteria has drastically narrowed down the therapeutic options against them. This limitation has led clinicians to reappraise the clinical application of polymyxins, an old class of cationic, cyclic polypeptide antibiotics....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
